• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肌病:发病机制和治疗的批判性综述。

Inflammatory muscle diseases: a critical review on pathogenesis and therapies.

机构信息

Department of Neurosciences, Imperial College, London, UK.

出版信息

Curr Opin Pharmacol. 2010 Jun;10(3):346-52. doi: 10.1016/j.coph.2010.03.001. Epub 2010 Apr 19.

DOI:10.1016/j.coph.2010.03.001
PMID:20409756
Abstract

Based on unique clinicopathological criteria, the most common immune inflammatory muscle disorders include Dermatomyositis (DM), Polymyositis (PM), Necrotizing Myositis (NM), and sporadic Inclusion Body Myositis (sIBM). DM is an undeniably a complement-mediated microangiopathy with destruction of capillaries, hypoperfusion, and inflammatory cell stress on the perifascicular regions. Necrotizing Myopathy is a poorly studied subacute myopathy triggered by toxic, viral, or autoimmune factors with macrophages as the final effector cells. In PM and IBM cytotoxic CD8-positive T-cells clonally expand in situ and invade MHC-I-expressing muscle fibers. In sIBM, in addition to autoimmune inflammation, there are degenerative features characterized by vacuolization and accumulation of stressor and amyloid-related molecules. Advances in the immunobiology of these disorders are discussed including the interaction between pro-inflammatory and beta-amyloid or stressor proteins. A critical review regarding tissue biomarkers and strategies for more effective treatments are presented.

摘要

基于独特的临床病理标准,最常见的免疫炎症性肌肉疾病包括皮肌炎(DM)、多发性肌炎(PM)、坏死性肌病(NM)和散发性包涵体肌炎(sIBM)。DM 是一种不可否认的补体介导的微血管病,伴有毛细血管破坏、灌注不足和血管周围区域的炎症细胞应激。坏死性肌病是一种研究甚少的亚急性肌病,由毒性、病毒或自身免疫因素触发,巨噬细胞是最终的效应细胞。在 PM 和 IBM 中,细胞毒性 CD8 阳性 T 细胞原位克隆扩增并侵入 MHC-I 表达的肌纤维。在 sIBM 中,除了自身免疫炎症外,还存在退行性特征,表现为空泡化和应激和淀粉样相关分子的积累。本文讨论了这些疾病的免疫生物学进展,包括促炎和β-淀粉样或应激蛋白之间的相互作用。还提出了关于组织生物标志物和更有效治疗策略的批判性综述。

相似文献

1
Inflammatory muscle diseases: a critical review on pathogenesis and therapies.炎症性肌病:发病机制和治疗的批判性综述。
Curr Opin Pharmacol. 2010 Jun;10(3):346-52. doi: 10.1016/j.coph.2010.03.001. Epub 2010 Apr 19.
2
Review: An update on inflammatory and autoimmune myopathies.综述:炎症性和自身免疫性肌病的最新进展。
Neuropathol Appl Neurobiol. 2011 Apr;37(3):226-42. doi: 10.1111/j.1365-2990.2010.01153.x.
3
Pathogenesis and therapies of immune-mediated myopathies.免疫介导性肌病的发病机制和治疗方法。
Autoimmun Rev. 2012 Jan;11(3):203-6. doi: 10.1016/j.autrev.2011.05.013. Epub 2011 May 18.
4
Pathophysiology of inflammatory and autoimmune myopathies.炎症性和自身免疫性肌病的病理生理学
Presse Med. 2011 Apr;40(4 Pt 2):e237-47. doi: 10.1016/j.lpm.2011.01.005. Epub 2011 Mar 15.
5
Update on idiopathic inflammatory myopathies.特发性炎性肌病的最新进展。
Autoimmunity. 2006 May;39(3):161-70. doi: 10.1080/08916930600622132.
6
Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.肌肉炎性疾病:多发性肌炎、皮肌炎及包涵体肌炎的研究进展
Curr Opin Neurol. 2004 Oct;17(5):561-7. doi: 10.1097/00019052-200410000-00006.
7
Potential therapeutic targets for idiopathic inflammatory myopathies.特发性炎性肌病的潜在治疗靶点。
Drug News Perspect. 2006 Nov;19(9):549-57. doi: 10.1358/dnp.2006.19.9.1050424.
8
Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.包涵体肌炎肌肉中上调的诱导性共刺激分子(ICOS)及其配体:对CD8 + T细胞细胞毒性的意义
Brain. 2004 May;127(Pt 5):1182-90. doi: 10.1093/brain/awh148. Epub 2004 Mar 26.
9
[Pathogenesis of primary inflammatory myopathies].[原发性炎性肌病的发病机制]
Presse Med. 2004 Nov 20;33(20):1444-50. doi: 10.1016/s0755-4982(04)98952-x.
10
Inflammatory, immune, and viral aspects of inclusion-body myositis.包涵体肌炎的炎症、免疫及病毒学方面
Neurology. 2006 Jan 24;66(2 Suppl 1):S33-8. doi: 10.1212/01.wnl.0000192129.65677.87.

引用本文的文献

1
G-Protein-Coupled Estrogen Receptor (GPER) in Inflammatory Myopathies.炎症性肌病中的G蛋白偶联雌激素受体(GPER)
Neurol Int. 2025 Jul 17;17(7):109. doi: 10.3390/neurolint17070109.
2
Lung involvement is a risk factor for treatment resistance in patients with polymyositis and dermatomyositis.肺部受累是多发性肌炎和皮肌炎患者治疗抵抗的一个危险因素。
Arch Rheumatol. 2025 Mar 17;40(1):72-79. doi: 10.46497/ArchRheumatol.2025.10989. eCollection 2025 Mar.
3
Hypothyroidism and dermato/polymyositis: a two-sample Mendelian randomization study.
甲状腺功能减退症与皮肌炎/多发性肌炎:两样本孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Sep 4;15:1361581. doi: 10.3389/fendo.2024.1361581. eCollection 2024.
4
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review.特发性炎性肌病中的身体活动:基于文献回顾的两种干预建议。
Clin Rheumatol. 2022 Mar;41(3):593-615. doi: 10.1007/s10067-021-05954-7. Epub 2021 Oct 19.
5
Autoimmunity as the comet tail of COVID-19 pandemic.自身免疫作为新冠疫情的“彗尾”。
World J Clin Cases. 2020 Sep 6;8(17):3621-3644. doi: 10.12998/wjcc.v8.i17.3621.
6
Polymyositis and dermatomyositis - challenges in diagnosis and management.多发性肌炎和皮肌炎——诊断与管理中的挑战
J Transl Autoimmun. 2019 Oct 8;2:100018. doi: 10.1016/j.jtauto.2019.100018. eCollection 2019 Dec.
7
Exercise training attenuates insulin resistance and improves β-cell function in patients with systemic autoimmune myopathies: a pilot study.运动训练可减轻系统性自身免疫性肌病患者的胰岛素抵抗并改善β细胞功能:一项初步研究。
Clin Rheumatol. 2019 Dec;38(12):3435-3442. doi: 10.1007/s10067-019-04738-4. Epub 2019 Aug 10.
8
Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies.他汀类药物在血脂异常和稳定的全身性自身免疫性肌病患者中的安全性。
Rheumatol Int. 2019 Feb;39(2):311-316. doi: 10.1007/s00296-018-4215-x. Epub 2018 Dec 5.
9
Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis.包涵体肌炎的临床、组织学和免疫组织化学表现。
Biomed Res Int. 2018 Jan 29;2018:5069042. doi: 10.1155/2018/5069042. eCollection 2018.
10
Mediators and Patterns of Muscle Loss in Chronic Systemic Inflammation.慢性全身炎症中肌肉损失的介质与模式
Front Physiol. 2018 Apr 24;9:409. doi: 10.3389/fphys.2018.00409. eCollection 2018.